The Athletes Heart
The Athletes Heart
"Athlete’s heart" is a well-recognized physiological adaptation of the cardiovascular system that develops in response to long-term, intensive endurance or strength training. It’s not a disease, but rather the body’s way of remodeling itself to meet the sustained demands of high-level physical activity. Understanding it is important because its features can overlap with those of pathological heart disease (e.g., hypertrophic cardiomyopathy), making careful distinction essential in clinical practice.
Cardiac enlargement: The heart increases in size, particularly the left ventricle (LV).
Left ventricular hypertrophy (LVH):
Endurance training (e.g., marathon running, cycling, rowing): produces eccentric hypertrophy — the chamber dilates and the walls thicken proportionally, increasing stroke volume.
Strength training (e.g., weightlifting, wrestling): produces concentric hypertrophy — the walls thicken without much chamber dilation, due to pressure overload.
Right ventricle: May also dilate, especially in endurance athletes, which can mimic arrhythmogenic right ventricular cardiomyopathy (ARVC).
Left atrial enlargement: Common in endurance athletes due to chronic volume load.
Bradycardia: Resting heart rates often <60 bpm, sometimes <40 bpm, due to increased vagal tone and stroke volume.
Enhanced diastolic filling: Ventricles relax more efficiently, improving cardiac output at lower heart rates.
Increased stroke volume & cardiac output: Both at rest and during exercise, enabling better oxygen delivery to tissues.
Normal or super-normal systolic function: Left ventricular ejection fraction is preserved or even slightly higher at rest, and augments appropriately during exertion.
ECG changes are common, including:
Sinus bradycardia, junctional rhythms, or first-degree AV block
Early repolarization patterns (ST elevation in precordial leads)
Increased QRS voltage consistent with LVH or RVH
Incomplete right bundle branch block
These are usually benign, but can mimic pathology.
A key clinical challenge is distinguishing athlete’s heart from cardiomyopathies (hypertrophic cardiomyopathy, dilated cardiomyopathy, ARVC), since both can show enlarged or thickened ventricles.
Clues suggesting athlete’s heart rather than pathology:
Symmetrical LV hypertrophy with wall thickness usually <12–15 mm (though can rarely be higher in elite male athletes).
Normal diastolic function and absence of fibrosis on cardiac MRI.
Regression of hypertrophy after detraining (within weeks to months).
Absence of family history or symptoms (syncope, arrhythmia, sudden death).
ECG changes consistent with training rather than malignant arrhythmias.
Clues suggesting disease:
Marked asymmetrical LV hypertrophy (>15 mm, especially septal)
LV outflow obstruction, impaired relaxation
Fibrosis on cardiac MRI (late gadolinium enhancement)
Family history of cardiomyopathy or sudden cardiac death
Ventricular arrhythmias on exercise testing or Holter monitoring
Benign adaptation: In most athletes, this remodeling is healthy and reversible.
Performance advantage: Athlete’s heart improves cardiac efficiency, oxygen delivery, and exercise tolerance.
Diagnostic challenge: Misinterpreting it as disease may lead to unnecessary disqualification from sport; conversely, missing underlying cardiomyopathy risks sudden cardiac death.
Screening importance: Especially in young athletes, where distinguishing physiological from pathological changes is critical.
Echocardiography: First-line for assessing chamber size, wall thickness, and diastolic function.
Cardiac MRI: Provides more precise measurements and can identify fibrosis.
ECG: To assess conduction changes and differentiate physiological vs. pathological findings.
Exercise testing: Evaluates functional capacity and arrhythmias.
Genetic testing: Considered if there’s suspicion of inherited cardiomyopathy.
Detraining trial: Reassessment after 3 months of reduced training can help distinguish athlete’s heart (which regresses) from pathology (which persists).
✅ In summary:
Athlete’s heart is a reversible, physiological enlargement of the heart due to long-term training. It involves chamber dilation, mild hypertrophy, bradycardia, and benign ECG changes, all of which enhance exercise capacity. The main clinical challenge lies in distinguishing it from pathological cardiomyopathies, which can mimic its appearance but carry significant risk.
Dr Ensam is a sports cardiologist and can provide professional & high level amateur athletes with a comprehensive cardiac assessment.